Marilyn E Morris

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 24

Top Topics

Diabetic Nephropathy

Top Venues

Molecular pharmaceutics

The AAPS journal

Drug metabolism and disposition: the biological fate of chemicals

This page only lists publications with an associated author ORCID identifier.

Publications

Mark A Bryniarski, Ruben M Sandoval, Donna M Ruszaj, John Fraser-McArthur, Benjamin M Yee, Rabi Yacoub, Lee D Chaves, Silvia B Campos-Bilderback, Bruce A Molitoris, Marilyn E Morris
Defining the Intravital Renal Disposition of Fluorescence-Quenched Exenatide. Molecular pharmaceutics 20 (2) (2023)
Mark A Bryniarski, Ruben M Sandoval, Donna M Ruszaj, John Fraser-McArthur, Benjamin M Yee, Rabi Yacoub, Lee D Chaves, Silvia B Campos-Bilderback, Bruce A Molitoris, Marilyn E Morris
Defining the Intravital Renal Disposition of Fluorescence-Quenched Exenatide. Molecular pharmaceutics 20 (2) (2023)
Mark A Bryniarski, Ruben M Sandoval, Donna M Ruszaj, John Fraser-McArthur, Benjamin M Yee, Rabi Yacoub, Lee D Chaves, Silvia B Campos-Bilderback, Bruce A Molitoris, Marilyn E Morris
Defining the Intravital Renal Disposition of Fluorescence-Quenched Exenatide. Molecular pharmaceutics 20 (2) (2023)
Mark A Bryniarski, Ruben M Sandoval, Donna M Ruszaj, John Fraser-McArthur, Benjamin M Yee, Rabi Yacoub, Lee D Chaves, Silvia B Campos-Bilderback, Bruce A Molitoris, Marilyn E Morris
Defining the Intravital Renal Disposition of Fluorescence-Quenched Exenatide. Molecular pharmaceutics 20 (2) (2023)
Mark A Bryniarski, Ruben M Sandoval, Donna M Ruszaj, John Fraser-McArthur, Benjamin M Yee, Rabi Yacoub, Lee D Chaves, Silvia B Campos-Bilderback, Bruce A Molitoris, Marilyn E Morris
Defining the Intravital Renal Disposition of Fluorescence-Quenched Exenatide. Molecular pharmaceutics (2023)
Mark A Bryniarski, Ruben M Sandoval, Donna M Ruszaj, John Fraser-McArthur, Benjamin M Yee, Rabi Yacoub, Lee D Chaves, Silvia B Campos-Bilderback, Bruce A Molitoris, Marilyn E Morris
Defining the Intravital Renal Disposition of Fluorescence-Quenched Exenatide. Molecular pharmaceutics 20 (2) (2023)
Tianjing Ren, Robert S Jones, Marilyn E Morris
Untargeted metabolomics identifies the potential role of monocarboxylate transporter 6 (MCT6/SLC16A5) in lipid and amino acid metabolism pathways. Pharmacology research & perspectives 10 (3) (2022)
Kristin E Follman, Marilyn E Morris
Treatment of γ-Hydroxybutyrate (GHB) Overdose with the GABA B Antagonist SGS742. The Journal of pharmacology and experimental therapeutics (2022)
Mark A Bryniarski, Bei Zhao, Lee D Chaves, Jakob Hauge Mikkelsen, Benjamin M Yee, Rabi Yacoub, Shichen Shen, Mette Madsen, Marilyn E Morris
Immunoglobulin G Is a Novel Substrate for the Endocytic Protein Megalin. The AAPS journal 23 (2) (2021)
Nisha V Kwatra, Marilyn E Morris
Toxicokinetic/Toxicodynamic Interaction Studies in Rats between the Drugs of Abuse γ-Hydroxybutyric Acid and Ketamine and Treatment Strategies for Overdose. Pharmaceutics 13 (5) (2021)
Melanie A Felmlee, Bridget L Morse, Marilyn E Morris
γ-Hydroxybutyric Acid: Pharmacokinetics, Pharmacodynamics, and Toxicology. The AAPS journal 23 (1) (2021)
Vivian Rodriguez-Cruz, Tianjing Ren, Marilyn E Morris
Drug-drug interaction between diclofenac and gamma-hydroxybutyric acid. Biopharmaceutics & drug disposition 42 (8) (2021)
Robert S Jones, Donna Ruszaj, Mark D Parker, Marilyn E Morris
Contribution of Monocarboxylate Transporter 6 to the Pharmacokinetics and Pharmacodynamics of Bumetanide in Mice. Drug metabolism and disposition: the biological fate of chemicals 48 (9) (2020)
Mark A Bryniarski, Tianjing Ren, Abbas R Rizvi, Anthony M Snyder, Marilyn E Morris
Targeting the Choroid Plexuses for Protein Drug Delivery. Pharmaceutics 12 (10) (2020)
Xiaowen Guan, Marilyn E Morris
In Vitro and In Vivo Efficacy of AZD3965 and Alpha-Cyano-4-Hydroxycinnamic Acid in the Murine 4T1 Breast Tumor Model. The AAPS journal 22 (4) (2020)
Amy Lavelle, Marilyn E Morris
Women in the Pharmaceutical Sciences: Honoring Our Pioneers. The AAPS journal 22 (6) (2020)
Xiaowen Guan, Vivian Rodriguez-Cruz, Marilyn E Morris
Cellular Uptake of MCT1 Inhibitors AR-C155858 and AZD3965 and Their Effects on MCT-Mediated Transport of L-Lactate in Murine 4T1 Breast Tumor Cancer Cells. The AAPS journal 21 (2) (2019)
Xiaowen Guan, Marilyn E Morris
Pharmacokinetics of the Monocarboxylate Transporter 1 Inhibitor AZD3965 in Mice: Potential Enterohepatic Circulation and Target-Mediated Disposition. Pharmaceutical research 37 (1) (2019)
Kristin E Follman, Marilyn E Morris
Simulation-Based Analysis of the Impact of Renal Impairment on the Pharmacokinetics of Highly Metabolized Compounds. Pharmaceutics 11 (3) (2019)
Kristin E Follman, Marilyn E Morris
Treatment of γ-Hydroxybutyric Acid and γ-Butyrolactone Overdose with Two Potent Monocarboxylate Transporter 1 Inhibitors, AZD3965 and AR-C155858. The Journal of pharmacology and experimental therapeutics 370 (1) (2019)
Xiaowen Guan, Mark A Bryniarski, Marilyn E Morris
In Vitro and In Vivo Efficacy of the Monocarboxylate Transporter 1 Inhibitor AR-C155858 in the Murine 4T1 Breast Cancer Tumor Model. The AAPS journal 21 (1) (2018)
Kristin E Follman, Rutwij A Dave, Marilyn E Morris
Effects of renal impairment on transporter-mediated renal reabsorption of drugs and renal drug-drug interactions: A simulation-based study. Biopharmaceutics & drug disposition 39 (4) (2018)
Kristin E Follman, Marilyn E Morris
Prediction of the Effects of Renal Impairment on Clearance for Organic Cation Drugs that Undergo Renal Secretion: A Simulation-Based Study. Drug metabolism and disposition: the biological fate of chemicals 46 (5) (2018)
Robert S Jones, Mark D Parker, Marilyn E Morris
Quercetin, Morin, Luteolin, and Phloretin Are Dietary Flavonoid Inhibitors of Monocarboxylate Transporter 6. Molecular pharmaceutics 14 (9) (2017)